T80.A19D Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter

Name of the Condition

• Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter.

Summary

This condition describes a hemolytic transfusion reaction resulting from non-ABO blood group incompatibility, occurring during a subsequent encounter. It involves immune-mediated destruction of transfused red blood cells due to reactions against minor blood group antigens, with clinical manifestations that may persist or recur after the initial transfusion event.

Causes

Non-ABO incompatibility with hemolytic transfusion reactions is caused by preformed antibodies in the recipient that target minor blood group antigens (e.g., Rh, Kell, Duffy, Kidd) present in donor blood. These antibodies may develop from prior sensitization through pregnancy, previous transfusions, or organ transplants. The reaction is triggered when incompatible blood is transfused, leading to complement activation and red blood cell lysis.

Risk Factors

• Prior exposure to non-ABO antigens (e.g., through pregnancy or previous transfusions)
• History of multiple transfusions
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or flushing)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Hemolysis (evidenced by dark urine or jaundice)

Diagnosis

Diagnosis involves clinical evaluation of symptoms, laboratory testing for hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and confirmation of non-ABO antibody presence. Transfusion records and antibody screening help identify the causative antigen. Imaging or additional tests may assess organ involvement.

Treatment Options

Management focuses on discontinuing the transfusion, supportive care (e.g., fluids, oxygen), and treating hemolysis (e.g., diuretics, renal protection). Severe cases may require transfusion of compatible blood, corticosteroids, or plasma exchange. Monitoring for complications like renal failure is critical.

Prognosis and Follow-Up

Prognosis depends on the severity of hemolysis and organ involvement. Most patients recover with prompt treatment, but delayed or severe reactions may lead to long-term complications. Follow-up includes monitoring for recurrent symptoms, repeat antibody screening, and evaluation of organ function.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multi-organ dysfunction
• Recurrent hemolytic episodes
• Long-term antibody sensitization

Lifestyle & Prevention

• Ensure accurate blood typing and crossmatching before transfusions.
• Use leukoreduced or washed blood products in high-risk patients.
• Maintain thorough transfusion records and patient history.
• Educate patients on reporting transfusion-related symptoms promptly.

When to Seek Professional Help

Seek immediate medical attention if symptoms like fever, chills, shortness of breath, or dark urine occur after a transfusion. Persistent or worsening symptoms, signs of shock, or new organ dysfunction also require urgent evaluation.

Tips for Medical Coders

Document the subsequent encounter context, including the timing relative to the initial transfusion and any ongoing management. Specify non-ABO incompatibility details (e.g., antigen involved, antibody screening results) to support code assignment. Ensure clinical correlation between symptoms and laboratory findings for accurate coding.